Literature DB >> 28803243

Lithium Sensitivity of Store Operated Ca2+ Entry and Survival of Fibroblasts Isolated from Chorea-Acanthocytosis Patients.

Lisann Pelzl1, Bhaeldin Elsir1, Itishri Sahu1, Rosi Bissinger1, Yogesh Singh1, Basma Sukkar1, Sabina Honisch1, Ludger Schoels2,3, Mohamed Jemaà4, Elisabeth Lang5, Alexander Storch6,7, Andreas Hermann8,9, Christos Stournaras1,10, Florian Lang11,12.   

Abstract

BACKGROUND: The widely expressed protein chorein fosters activation of the phosphoinositide 3 kinase (PI3K) pathway thus supporting cell survival. Loss of function mutations of the chorein encoding gene VPS13A (vacuolar protein sorting-associated protein 13A) causes chorea-acanthocytosis (ChAc), a neurodegenerative disorder paralleled by deformations of erythrocytes. In mice, genetic knockout of chorein leads to enhanced neuronal apoptosis. PI3K dependent signalling upregulates Orai1, a pore forming channel protein accomplishing store operated Ca2+ entry (SOCE). Increased Orai1 expression and SOCE have been shown to confer survival of tumor cells. SOCE could be up-regulated by lithium. The present study explored, whether SOCE and/or apoptosis are altered in ChAc fibroblasts and could be modified by lithium treatment.
METHODS: Fibroblasts were isolated from ChAc patients and age-matched healthy volunteers. Cytosolic Ca2+ activity ([Ca2+]i) was estimated from Fura-2-fluorescence, SOCE from increase of [Ca2+]i following Ca2+ re-addition after Ca2+-store depletion with sarcoendoplasmatic Ca2+-ATPase (SERCA) inhibitor thapsigargin (1 µM), and apoptosis from annexin-V/propidium iodide staining quantified in flow cytometry.
RESULTS: SOCE was significantly smaller in ChAc fibroblasts than in control fibroblasts. Lithium (2 mM, 24 hours) significantly increased and Orai1 blocker 2-Aminoethoxydiphenyl Borate (2-APB, 50 µM, 24 hours) significantly decreased SOCE. Annexin-V-binding and propidium iodide staining were significantly higher in ChAc fibroblasts than in control fibroblasts. In ChAc fibroblasts annexin-V-binding and propidium iodide staining were significantly decreased by lithium treatment, significantly increased by 2-APB and virtually lithium insensitive in the presence of 2-APB.
CONCLUSIONS: In ChAc fibroblasts, downregulation of SOCE contributes to enhanced susceptibility to apoptosis. Both, decreased SOCE and enhanced apoptosis of ChAc fibroblasts can be reversed by lithium treatment.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Apoptosis; Calcium; Cell membrane scrambling; Lithium; Neurodegeneration; Orai1; SOCE

Mesh:

Substances:

Year:  2017        PMID: 28803243     DOI: 10.1159/000479901

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  11 in total

1.  Decreased Na+/K+ ATPase Expression and Depolarized Cell Membrane in Neurons Differentiated from Chorea-Acanthocytosis Patients.

Authors:  Zohreh Hosseinzadeh; Stefan Hauser; Yogesh Singh; Lisann Pelzl; Stefanie Schuster; Yamini Sharma; Philip Höflinger; Nefeli Zacharopoulou; Christos Stournaras; Daniel L Rathbun; Eberhart Zrenner; Ludger Schöls; Florian Lang
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

2.  VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites.

Authors:  Nikit Kumar; Marianna Leonzino; William Hancock-Cerutti; Florian A Horenkamp; PeiQi Li; Joshua A Lees; Heather Wheeler; Karin M Reinisch; Pietro De Camilli
Journal:  J Cell Biol       Date:  2018-08-09       Impact factor: 10.539

3.  Yeast-model-based study identified myosin- and calcium-dependent calmodulin signalling as a potential target for drug intervention in chorea-acanthocytosis.

Authors:  Piotr Soczewka; Damian Kolakowski; Iwona Smaczynska-de Rooij; Weronika Rzepnikowska; Kathryn R Ayscough; Joanna Kaminska; Teresa Zoladek
Journal:  Dis Model Mech       Date:  2019-01-28       Impact factor: 5.758

4.  Partial Inhibition of Calcineurin Activity by Rcn2 as a Potential Remedy for Vps13 Deficiency.

Authors:  Patrycja Wardaszka; Piotr Soczewka; Marzena Sienko; Teresa Zoladek; Joanna Kaminska
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

5.  Case Report: Chorea-Acanthocytosis Presents as Epilepsy in a Consanguineous Family With a Nonsense Mutation of in VPS13A.

Authors:  Fang-Mei Luo; Ming-Xing Deng; Rong Yu; Lv Liu; Liang-Liang Fan
Journal:  Front Neurosci       Date:  2021-02-10       Impact factor: 4.677

6.  Lithium Reduces Migration and Collagen Synthesis Activity in Human Cardiac Fibroblasts by Inhibiting Store-Operated Ca2+ Entry.

Authors:  Pao-Huan Chen; Cheng-Chih Chung; Yuan-Feng Lin; Yu-Hsun Kao; Yi-Jen Chen
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

7.  Unraveling the Spatiotemporal Distribution of VPS13A in the Mouse Brain.

Authors:  Esther García-García; Nerea Chaparro-Cabanillas; Albert Coll-Manzano; Maria Carreras-Caballé; Albert Giralt; Daniel Del Toro; Jordi Alberch; Mercè Masana; Manuel J Rodríguez
Journal:  Int J Mol Sci       Date:  2021-12-01       Impact factor: 5.923

8.  The GTPase Arf1 Is a Determinant of Yeast Vps13 Localization to the Golgi Apparatus.

Authors:  Damian Kolakowski; Weronika Rzepnikowska; Aneta Kaniak-Golik; Teresa Zoladek; Joanna Kaminska
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

9.  Changes in Blood Cell Deformability in Chorea-Acanthocytosis and Effects of Treatment With Dasatinib or Lithium.

Authors:  Felix Reichel; Martin Kräter; Kevin Peikert; Hannes Glaß; Philipp Rosendahl; Maik Herbig; Alejandro Rivera Prieto; Alexander Kihm; Giel Bosman; Lars Kaestner; Andreas Hermann; Jochen Guck
Journal:  Front Physiol       Date:  2022-04-04       Impact factor: 4.755

10.  Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.

Authors:  Kevin Peikert; Hannes Glaß; Enrica Federti; Alessandro Matte; Lisann Pelzl; Katja Akgün; Tjalf Ziemssen; Rainer Ordemann; Florian Lang; The Network For Translational Research For Neuroacanthocytosis Patients; Lucia De Franceschi; Andreas Hermann
Journal:  J Pers Med       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.